Search Results - "Gorustovich, O. A."
-
1
Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations
Published in Familial cancer (2023)“…The spectrum of BRCA1/2 mutations demonstrates significant interethnic variations. We analyzed for the first time the entire BRCA1/2 coding region in 340…”
Get full text
Journal Article -
2
Allelic variant 6A (rs35068180) of the MMP-3 promoter region as a predictor of cardiotoxicity after the end of adjuvant chemotherapy with doxorubicin in patients with breast cancer
Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (01-02-2024)“…Aim. To evaluate the relationship of polymorphic variants rs2232228 of the HAS3 gene, rs8187710 of the ABCC2 gene, rs35068180 of the MMP-3 gene with…”
Get full text
Journal Article -
3
PREDICTIVE RESPONSE MARKERS FOR IMMUNE RESPONSE BLOCKS
Published in Sibirskiĭ onkologicheskiĭ zhurnal (02-09-2020)“…Despite the unprecedented success in using immune checkpoint inhibitors in the treatment of lung cancer, melanoma, hypermutable tumors of various localization,…”
Get full text
Journal Article -
4
GENETIC BIOMARKERS OF GLIAL BRAIN TUMORS: IDH1 AND IDH2 MUTATIONS
Published in Sibirskiĭ onkologicheskiĭ zhurnal (02-09-2020)“…Introduction. Mutations in the isocytrate dehydrogenase 1 and 2 genes (IDH1 and IDH2) are considered driver genetic events in gliomas. Their frequency reaches…”
Get full text
Journal Article -
5
Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-ICOS risk groups
Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (28-07-2024)“…Aim . To study the association of rs2232228 ( HAS3 gene), rs2229774 ( RARG gene), rs1056892 ( CBR3 gene), rs1786814 ( CELF4 gene), rs1695 ( GSTP1 gene),…”
Get full text
Journal Article